Kansas City, MO: A preliminary settlement has been reached in the nation's only certified consumer fraud class action lawsuit with Merck & Co. Inc. regarding Vioxx, the company's prescription pain reliever used for the treatment of certain arthritis conditions.
The class action lawsuit involved claims alleging that Merck's promotion and sale of Vioxx constituted unlawful and unfair business practices under the Missouri Merchandising Practices Act.
The previously certified consumer class action, filed in 2004 in Jackson County, Missouri, sought $220 million in damages for all Missouri residents who purchased Vioxx before it was removed from the market in September 2004.
Under the settlement terms, qualifying Missouri consumers of Vioxx may be reimbursed in full for their Vioxx purchases. The common fund settlement provides for payment to class members under two options: (1) a one-time cash payment of $180 to Settlement Class Members who submit a valid claim form with a declaration under oath (but no documentary proof of payment required) and (2) $90 for each month of Vioxx purchases supported by a declaration under oath with documentary proof of payment, such as a letter from the prescribing physician.
In addition to paying the claims of qualifying class members, the settlement requires Merck to pay for all costs associated with the notice and administration of the settlement as well as court-approved attorneys' fees and expenses incurred by the Class. Any amount awarded in attorneys' fees and expenses will not reduce the cash benefits paid to the Class.
The settlement must be approved by the Jackson County Circuit Court before it becomes final and any payments can be made to qualifying class members.
